John Smither

John Smither

Direttore Finanziario/CFO presso MBX BIOSCIENCES, INC.

Patrimonio netto: 356 917 $ in data 31/05/2026

73 anni
Health Technology
Commercial Services
Consumer Services

Profilo

John William Smither is currently an Independent Director at Genelux Corp.
since 2023, an Independent Non-Executive Director at NewAmsterdam Pharma Co. NV since 2023, a Director at eFFECTOR Therapeutics Operations, Inc. since 2018, a Member of The American Institute of Certified Public Accountants, a Member of Financial Executives International, a Member of California Society of Certified Public Accountants, and is set to be Chief Financial Officer at MBX Biosciences, Inc. starting in 2026.
Former positions include Independent Director at Achaogen, Inc. from 2013 to 2020, Independent Director at Principia Biopharma, Inc. in 2019, Director at Dompe Biotec SpA, Independent Director at eFFECTOR Therapeutics, Inc. from 2018 to 2023, Independent Director at Applied Molecular Transport, Inc. from 2022 to 2023, Vice President-Finance & Administration at Amgen, Inc. from 2001 to 2004, Chief Financial Officer at Kythera Biopharmaceuticals LLC from 2007 to 2015, Audit Partner at Ernst & Young LLP (Missouri), Chief Financial Officer at Amgen Europe BV from 2001 to 2004, Chief Financial Officer at Kite Pharma, Inc. from 2017 to 2018, Chief Financial Officer at Unity Biotechnology, Inc. from 2016 to 2017, Chief Financial Officer at Sienna Biopharmaceuticals, Inc. from 2016 to 2017 and again from 2018 to 2019, Chief Financial Officer at Arcutis Biotherapeutics, Inc. from 2019 to 2021 and from 2023 to 2024.
Education includes undergraduate studies at California State University-Los Angeles.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValutazioneData di valutazione
01/07/2026 91.403 ( 0,2% ) 278 779 $ 31/05/2026
15/04/2026 2.320 ( 0% ) 78 138 $ 31/05/2026

Posizioni attive di John Smither

SocietàPosizioneInizio
FRAZIER LIFESCIENCES ACQUISITION CORPORATION Direttore/Membro del Consiglio 01/01/2023
GENELUX CORPORATION Direttore/Membro del Consiglio 11/09/2023
MBX BIOSCIENCES, INC. Direttore Finanziario/CFO 01/03/2026
Direttore/Membro del Consiglio 23/03/2018
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -

Precedenti posizioni note di John Smither

SocietàPosizioneFine
ARCUTIS BIOTHERAPEUTICS, INC. Direttore Finanziario/CFO 10/04/2024
APPLIED MOLECULAR TRANSPORT INC. Direttore/Membro del Consiglio 27/12/2023
░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di John Smither

Formazione di John Smither

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

58

Relazioni di 1° grado

21

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private21

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Commercial Services

Consumer Services

Commercial Services

Commercial Services

Health Technology

Distribution Services

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

  1. Mercati
  2. Insiders
  3. John Smither